Работы, на которые ссылается эта работа

Работ: 26

Работа: Peptide design of a competitive inhibitor for HMG‐CoA reductase based on statin structure

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Marion M. Bradford
Статья1976Цитирований: 59
ABI
A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
Mark A. Bradford
Статья1976Цитирований: 40
ABI
Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model
Michael J. S. Dewar, Eve G. Zoebisch, Eamonn F. Healy +1
Статья1985Цитирований: 17
ABI
Isolation and Identification of Peptides from Soy 11S-Globulin with Hypocholesterolemic Activity
Valeriy V. Pak, Minseon Koo, T. D. Kasymova +1
СтатьяProtein Hydrolysis and Bioactive PeptidesChemistry of Natural Compounds2005Цитирований: 14
ABI
Statin inhibition of HMG-CoA reductase: a 3-dimensional view
Eva S. Istvan
Обзорная статья2003Цитирований: 13
ABI
Structure—Activity Relationships of the Peptide Ile-Ala-Val-Pro and Its Derivatives Revealed Using the Semi-Empirical AM1 Method
Valeriy V. Pak, Minseon Koo, N. Lee +2
Статья2005Цитирований: 12
ABI
Amino Acid Substitution of Hypocholesterolemic Peptide Originated from Glycinin Hydrolyzate
Dae Young Kwon, Si Won Oh, Ji Soo Lee +5
Статья2002Цитирований: 11
ABI
Conformation Analysis of Ile-Ala-Val-Pro Peptide and Its Derivatives by Circular Dichroism
Valeriy V. Pak, Minseon Koo, Dae Young Kwon +1
СтатьяChemical Synthesis and AnalysisChemistry of Natural Compounds2004Цитирований: 11
ABI
Advances and Continuing Challenges in Achieving Realistic and Predictive Simulations of the Properties of Organic and Biological Molecules
Peter A. Kollman
Статья1996Цитирований: 11
ABI
Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality
Patricia R. Hebert
Статья1997Цитирований: 7
ABI
Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials
Daniel A. Eisenberg
Обзорная статья1998Цитирований: 6
ABI
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
Eva S. Istvan, J. Deisenhofer
Статья2001Цитирований: 6
ABI
Structures of the Peptide Leu-Pro-Tyr-Pro and Its Derivatives and the Nicotinamide Part of NADPH by a Semi-Empirical PM3 Method
Valeriy V. Pak, Meng-Yu Ku, Na Li +3
СтатьяEnzyme Structure and FunctionChemistry of Natural Compounds2005Цитирований: 5
ABI
Hypocholesterolemic Soybean Peptide (IAVP) Inhibits HMG-CoA Reductase in a Competitive Manner
Valeriy V. Pak, Minseon Koo, Nari Lee +4
Статья2005Цитирований: 5
ABI
9-Fluorenylmethoxycarbonyl amino-protecting group
Louis A. Carpino, Grace Han
Статья1972Цитирований: 5
ABI
SOLID‐PHASE PEPTIDE SYNTHESIS USING MILD BASE CLEAVAGE OF <i>N</i><sub>α</sub>FLUORENYLMETHYLOXYCARBONYLAMINO ACIDS, EXEMPLIFIED BY A SYNTHESIS OF DIHYDROSOMATOSTATIN
Chi‐Deu Chang, Johannes Meienhofer
Статья1978Цитирований: 4
ABI
Some multistep methods for use in molecular dynamics calculations
David Beeman
Статья1976Цитирований: 4
ABI
The structure of the catalytic portion of human HMG-CoA reductase
Eva S. Istvan
Обзорная статья2000Цитирований: 3
ABI
Evaluation of the hydrophobic parameters of the amino acid side chains of peptides and their application in QSAR and conformational studies
Tomoko Sotomatsu-Niwa, Akio Ogino
Статья1997Цитирований: 2
ABI
Immunogenicity of Peptide-vaccine Candidates Predicted by Molecular Dynamics Simulations
Clasien J. Oomen, Peter Hoogerhout, Alexandre M. J. J. Bonvin +6
Статья2003Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI